[1] World Health Organization (WHO). Preterm birth. 2023. https://www.who.int/en/news-room/fact-sheets/detail/preterm-birth. [2023-5-10].
[2] Cao GY, Liu J, Liu M. Global, regional, and national incidence and mortality of neonatal preterm birth, 1990-2019. JAMA Pediatr 2022;176(8):787 − 96.CrossRef
[3] Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL, et al. Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the sustainable development goals. Lancet Child Adolesc Health 2022;6(2):106 − 15.CrossRef
[4] Zhuang X, Cui AM, Wang Q, Cheng XY, Shen Y, Cai WH, et al. Liver dysfunction during pregnancy and its association with preterm birth in China: a prospective cohort study. Ebiomedicine 2017;26:152 − 6.CrossRef
[5] Sarkar M, Grab J, Dodge JL, Gunderson EP, Rubin J, Irani RA, et al. Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes. J Hepatol 2020;73(3):516 − 22.CrossRef
[6] Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet 2019;393(10174):899 − 909.CrossRef
[7] Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000;342(17):1266 − 71.CrossRef
[8] Zhang S, Wang Q, Shen H. Design of the national free proception health examination project in China. Natil Med J China 2015;95(3):162 − 5. https://doi.org/10.3760/cma.j.issn.0376-2491.2015.03.002. (In Chinese)
[9] Yang Y, Guo TL, Fu JR, Kuang J, Wang YY, Zhang Y, et al. Preconception thyrotropin levels and risk of adverse pregnancy outcomes in Chinese women aged 20 to 49 years. JAMA Netw Open 2021;4(4):e215723.CrossRef
[10] Wu HB, Yang Y, Jia JJ, Guo TL, Lei JM, Deng YZ, et al. Maternal preconception hepatitis b virus infection and risk of congenital heart diseases in offspring among Chinese women aged 20 to 49 years. JAMA Pediatr 2023;177(5):498 − 505.CrossRef
[11] Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005;5(3):215 − 29.CrossRef
[12] Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 2006;22(6):437 − 43.CrossRef
[13] Liangpunsakul S, Chalasani N. Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third national health and nutrition survey (Nhanes III). Am J Med Sci 2005;329(3):111 − 6.CrossRef
[14] Yamada J, Tomiyama H, Yambe M, Koji Y, Motobe K, Shiina K, et al. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis 2006;189(1):198 − 205.CrossRef
[15] Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371(9606):75 − 84.CrossRef
[16] Le Couteur DG, Blyth FM, Creasey HM, Handelsman DJ, Naganathan V, Sambrook PN, et al. The association of alanine transaminase with aging, frailty, and mortality. J Gerontol A Biol Sci Med Sci 2010;65(7):712 − 7.CrossRef
[17] Vespasiani-Gentilucci U, De Vincentis A, Ferrucci L, Bandinelli S, Antonelli Incalzi R, Picardi A. Low alanine aminotransferase levels in the elderly population: frailty, disability, sarcopenia, and reduced survival. J Gerontol A Biol Sci Med Sci 2018;73(7):925 − 30.CrossRef
[18] Williams KH, Sullivan DR, Nicholson GC, George J, Jenkins AJ, Januszewski AS, et al. Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: analysis of the fenofibrate intervention and event lowering in diabetes (field) study. Metabolism 2016;65(5):783 − 93.CrossRef